Skip to main content

MoneyWorks4Me

Lupin informs about press release

24 Jul 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, receipt of approval from the U.S. FDA for the Company’s Abbreviated New Drug Applications for Liraglutide Injection Single-Patient-Use Prefilled Pens and Glucagon for Injection vials.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..